• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Drug Procurement in Public Hospitals under the Public Procurement and Supplies Administration Act B.E. 2560 (2017)

วราวัลย์ จึงศิวะพรพงษ์; Warawan Chungsivapornpong; นิธิเจน กิตติรัชกุล; Nitichen Kittiratchakool; สุธาสินี คำหลวง; Suthasinee Kumluang; อรพรรณ อ่อนจร; Orapan Onjon; ศรีเพ็ญ ตันติเวสส; Sripen Tantivess;
Date: 2563-09-30
Abstract
The Public Procurement and Supplies Administration Act, B.E. 2560 (2017) came into force on 23 August 2017 to replace the Rule of the Office of the Prime Minister on Procurement, B.E. 2535 (1992). This Act aims to promote worthiness, transparency, efficiency, effectiveness, and accountability of government procurement. However, in practice, the Act introduces many more processes and details and lacks clear guidelines for operational compliance. This has impacted drug procurement in numerous ways such as longer procurement time, an increase in workload for staff, and the risk of drug shortage due to delays in the procurement process. The purpose of this study was to determine the current situation, issues faced, and impact on hospital workload by using a qualitative descriptive design. The data collection approach included reviews of various orders, regulations, and consequences affected by this Act, and in-depth interviews with drug procurement staff in 7 public hospitals, policymakers, and other stakeholders. Content analysis was employed for data analysis. The results revealed that one year after the Public Procurement and Supplies Administration Act, B.E. 2560 (2017) came into effect, drug procurement practices between hospitals varied depending on individual hospital policies and interpretations of the Act. In terms of hospital workload, procurement based on this Act led to an increase in overall workload such as the number of procured drugs, documentation, and operating expenses. Meanwhile, the number of hospital staff tasked with the procurement process was inadequate, and many aspects of the public procurement system and within hospitals themselves lacked readiness. Therefore, the Comptroller General’s Department and the Office of the Auditor General, as the agencies responsible for supervising operational compliance with the Public Procurement and Supplies Administration Act, should cooperate with public hospital management and public and private drug manufacturers and distributors to determine the optimal amount of staff required for procurement tasks. They should also support the use of information technology to develop a procurement document management system, and continuously monitor and assess the drug procurement process.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hsri-journal-v14n ...
Size: 322.5Kb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 2
This month: 91
This budget year: 1,936
This year: 917
All: 14,262
 

 
 


 
 
Show full item record
Collections
  • Articles [1366]

    บทความวิชาการ


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV